HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kati Maharry Selected Research

Urinary Tract Infections (Urinary Tract Infection)

10/2019Binimetinib, Encorafenib, and Cetuximab Triplet Therapy for Patients With BRAF V600E-Mutant Metastatic Colorectal Cancer: Safety Lead-In Results From the Phase III BEACON Colorectal Cancer Study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kati Maharry Research Topics

Disease

28Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
08/2014 - 05/2005
21Neoplasms (Cancer)
09/2019 - 05/2005
20Leukemia
04/2014 - 08/2005
4Colorectal Neoplasms (Colorectal Cancer)
01/2021 - 01/2017
2Breast Neoplasms (Breast Cancer)
09/2019 - 12/2014
1Anemia
10/2019
1Fatigue
10/2019
1Urinary Tract Infections (Urinary Tract Infection)
10/2019
1Breast Carcinoma In Situ
09/2019
1Carcinoma (Carcinomatosis)
09/2019
1Noninfiltrating Intraductal Carcinoma (DCIS)
09/2019
1Necrosis
06/2015
1Neoplasm Metastasis (Metastasis)
12/2014
1Multiple Myeloma
01/2013
1Myelodysplastic Syndromes (Myelodysplastic Syndrome)
01/2013
1Wilms Tumor (Wilm's Tumor)
10/2011
1Meningioma (Meningiomas)
07/2009
1Chromosome Aberrations (Chromosome Abnormalities)
08/2005

Drug/Important Bio-Agent (IBA)

15MicroRNAs (MicroRNA)IBA
09/2019 - 05/2008
4encorafenibIBA
01/2021 - 01/2017
4Cetuximab (Erbitux)FDA Link
01/2021 - 01/2017
4Proteins (Proteins, Gene)FDA Link
06/2015 - 05/2005
3binimetinibIBA
01/2021 - 10/2019
2Cytarabine (Cytosar-U)FDA LinkGeneric
09/2012 - 10/2008
2Core Binding Factors (Core-Binding Factor)IBA
04/2010 - 08/2005
2Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
10/2008 - 05/2008
2DNA (Deoxyribonucleic Acid)IBA
09/2008 - 07/2005
1Irinotecan (Camptosar)FDA LinkGeneric
01/2021
1Creatine Kinase (Creatine Phosphokinase)IBA
10/2019
1Biomarkers (Surrogate Marker)IBA
09/2019
1AlpelisibIBA
01/2017
1Differentiation AntigensIBA
12/2014
1LigandsIBA
06/2014
1c-Mer Tyrosine KinaseIBA
06/2014
1Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
06/2014
1CateninsIBA
04/2014
1integrin-linked kinaseIBA
04/2014
1Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA
04/2014
1IntegrinsIBA
04/2014
1OsteonectinIBA
04/2014
1Interleukin-2 (IL2)IBA
04/2014
1Cysteine (L-Cysteine)FDA Link
04/2014
1Genetic Markers (Genetic Marker)IBA
02/2014
1Lenalidomide (CC 5013)FDA Link
01/2013
1Protein Isoforms (Isoforms)IBA
01/2013
1AnthracyclinesIBA
09/2012
1GuanineIBA
10/2011
1AdenineFDA LinkGeneric
10/2011
1valspodar (PSC 833)IBA
09/2010
1Member 1 Subfamily B ATP Binding Cassette TransporterIBA
09/2010
1snRNP Core ProteinsIBA
08/2010
1Oxidoreductases (Dehydrogenase)IBA
05/2010
1isocitric acid (isocitrate)IBA
05/2010
1mouse MIRN29 microRNAIBA
04/2010
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
03/2010
1Histone MethyltransferasesIBA
09/2008
1Histones (Histone)IBA
09/2008
1NucleophosminIBA
05/2008
1RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
08/2007
1MethyltransferasesIBA
07/2005
1Histone Deacetylase InhibitorsIBA
07/2005
1Histone Deacetylases (Histone Deacetylase)IBA
07/2005
1oblimersen (G3139)IBA
05/2005

Therapy/Procedure

5Therapeutics
10/2019 - 12/2011
4Drug Therapy (Chemotherapy)
06/2015 - 02/2010
1Cell Transplantation
12/2011
1Salvage Therapy
08/2005
1Molecular Targeted Therapy
07/2005